A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation
A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation
The purpose of this study is to determine the efficacy and safety of Betahistine Mesilate in
 the treatment of patients with vertigo caused by Cerebral Infarction in posterior
 circulation.
Inclusion Criteria:

 1. Patients that have a clinical diagnosis of posterior circulation infarction and vertigo
 occurring within 1 month after the infarction.